Healthcare Services

Targeted Therapy Market Developments and Growth Opportunities Across 2026–2030

April 7, 2026April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Targeted Therapy Market By 2030 Starting From Its 2026 Size?

The targeted therapy market has seen significant expansion in recent years. It is anticipated to increase from $109.99 billion in 2025 to $118.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to several factors including the rising global incidence of cancer, increased funding for oncology research, broader adoption of monoclonal antibodies, advancements in molecular biology research, and a growing number of approvals for targeted cancer drugs.

The market for targeted therapy is projected to experience substantial expansion over the upcoming years. By 2030, its value is anticipated to reach $158.2 billion, demonstrating a compound annual growth rate (CAGR) of 7.6%. This projected growth is driven by several factors, including heightened investments in personalized medicine, the expanding application of AI in drug discovery, a wider embrace of precision diagnostics, an escalating need for less toxic cancer treatments, and increased oncology-related clinical trial activities. Key trends anticipated during this period encompass the accelerated development of precision oncology drugs, a greater reliance on biomarker-guided treatment choices, the proliferation of combined targeted therapies, the expanding utilization of companion diagnostics, and a sharper emphasis on designing drugs specific to tumor characteristics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

Which Market Drivers Are Supporting The Expansion Of The Targeted Therapy Market?

The projected expansion of the targeted therapy market is linked to the rising incidence of cancer. Cancer refers to diseases characterized by abnormal cells that proliferate uncontrollably and can invade nearby tissues. This treatment modality works by either deactivating signals that promote cancer cell growth or by inducing these cells to undergo programmed cell death. It utilizes drugs designed to precisely attack specific genes and proteins crucial for cancer cells’ survival and proliferation, thereby boosting its demand. As an illustration, the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported in January 2024 that cancer cases rose to 2,001,140 from 1,958,310 in 2023, indicating a 2.19% increase. Consequently, the growing occurrence of cancer is anticipated to fuel the expansion of the targeted therapy market.

Which Segment Categories Define The Targeted Therapy Market?

The targeted therapy market covered in this report is segmented –

1) By Type: Small Molecule Medicines, Monoclonal Antibodies

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

Subsegments:

1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

What Trends Are Projected To Affect The Targeted Therapy Market?

Companies active in the targeted therapy market are increasingly concentrating on strategic alliances to deliver consistent services to their clients. A strategic partnership involves an agreement between two or more firms or organizations that work together or support each other to achieve their respective goals. For example, in September 2023, Shine Technologies, a US-based pharmaceutical industry company manufacturing radioactive isotopes for medical applications, formed a partnership with Curadh MTR Inc., which is dedicated to advancing and accelerating the development of molecularly targeted radiation therapies for solid tumors. This alliance seeks to utilize the power of radioisotopes for accurate targeting and elimination of cancer cells, thereby providing fresh hope to patients and redefining the future of cancer treatment.

Who Are The Top Companies Competing In The Targeted Therapy Market?

Major companies operating in the targeted therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

Read the full targeted therapy market report here:

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

How Is The Targeted Therapy Market Distributed Across Key Geographic Regions?

North America was the largest region in the targeted therapy market in 2025. The regions covered in the targeted therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Targeted Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp

Browse Through More Reports Similar to the Global Targeted Therapy Market 2026, By The Business Research Company

Music Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/music-therapy-global-market-report

Neoantigen Targeted Therapies Global Market Report

https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report

Addictions Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795